Related Experiment Video
Updated: Jul 19, 2026
09:31
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
MALDI MS imaging of amyloid.
Markus Stoeckli1, Richard Knochenmuss, Gregor McCombie
1Novartis Institute for Biomedical Research, 4002 Basel, Switzerland.
Methods in Enzymology
|October 19, 2006
Summary
Label-free mass spectrometry enables simultaneous mapping of multiple molecules in tissues. This chapter details its use for detecting amyloid-beta (Abeta) peptides in mouse brain sections.
Area of Science:
- Biomedical Sciences
- Analytical Chemistry
- Neuroscience
Background:
- Label-free molecular imaging using mass spectrometry is an emerging technology.
- Simultaneous mapping of multiple analytes in biological tissues is crucial for understanding complex biological systems.
Purpose of the Study:
- To discuss the application of label-free mass spectrometry for detecting amyloid-beta (Abeta) peptides.
- To highlight the utility of this technique in analyzing mouse brain sections.
Main Methods:
- Mass spectrometry-based molecular imaging.
- Label-free detection techniques.
- Analysis of biological tissue sections.
Main Results:
- Simultaneous mapping of multiple analytes was achieved.
- Abeta peptides were successfully detected in mouse brain sections.
Conclusions:
- Label-free mass spectrometry is a powerful tool for molecular imaging in neuroscience.
- This technique facilitates the simultaneous detection and mapping of specific peptides in complex biological tissues.
